Greenwich LifeSciences, Inc. (GLSI)

NASDAQ: GLSI · Real-Time Price · USD

10.21

-0.23 (-2.25%)

Apr 25, 2025, 10:05 AM EDT - Market open

Greenwich LifeSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Net Income	-15.79	-8.89	-7.83	-4.57	-1.86	Upgrade
Depreciation & Amortization	0	0	0	0	0	Upgrade
Stock-Based Compensation	7.25	2.38	1.74	0.66	0.68	Upgrade
Change in Accounts Payable	0.92	0.04	-	-0.53	-0.09	Upgrade
Change in Other Net Operating Assets	0.34	-0	-0.12	0.14	0.12	Upgrade
Operating Cash Flow	-7.27	-6.48	-6.2	-4.29	-1.15	Upgrade
Short-Term Debt Repaid	-	-	-	-0.28	-0.36	Upgrade
Total Debt Repaid	-	-	-	-0.28	-0.36	Upgrade
Net Debt Issued (Repaid)	-	-	-	-0.28	-0.36	Upgrade
Issuance of Common Stock	4.37	-	-	3.36	33.65	Upgrade
Repurchase of Common Stock	-	-	-7.54	-	-	Upgrade
Other Financing Activities	-	-	-	-0.25	-3.48	Upgrade
Financing Cash Flow	4.37	-	-7.54	2.84	29.81	Upgrade
Net Cash Flow	-2.9	-6.48	-13.74	-1.46	28.65	Upgrade
Levered Free Cash Flow	-1.49	-3.42	-3.4	-2.59	-0.45	Upgrade
Unlevered Free Cash Flow	-1.49	-3.42	-3.4	-2.59	-0.45	Upgrade
Change in Net Working Capital	-1.27	-0.03	0.12	0.39	-0.03	Upgrade

Updated Apr 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q